Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Heidi Johansen-Berg, one of 11 University of Oxford biomedical and health scientists that the Academy of Medical Sciences has elected to its fellowship.

Election to Fellowship of the Academy of Medical Sciences is only granted to those who have achieved at the highest level in medical research. We are very fortunate to have Heidi as a colleague and a leader in NDCN. Many congratulations from everyone in the Department.
- Professor Kevin Talbot, Head of the Nuffield Department of Clinical Neurosciences

All were selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

For her ongoing stewardship of research that focuses on how the brain changes with learning, experience, and damage, Professor Heidi Johansen-Berg of the Nuffield Department of Clinical Neurosciences is elected a Fellow at the Academy.

She heads up the Plasticity Group, which aims to shed light on how the healthy brain responds to change with implications for understanding and treating disease, including testing new methods for rehabilitation after a stroke.

Professor Dame Anne Johnson PMedSci, President of the Academy of Medical Sciences, said: 'Although it is hard to look beyond the pandemic right now, I want to stress how important it is that the Academy Fellowship represents the widest diversity of biomedical and health sciences. The greatest health advances rely on the findings of many types of research, and on multidisciplinary teams and cross-sector and global collaboration.'

Similar stories

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.

Multiple heart-related conditions linked to triple dementia risk, regardless of genetics

Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.

NDCN research presented at Myasthenia Gravis conference

The 14th Quinquennial Myasthenia Gravis Federation of America International Conference was recently held in Miami with 450 delegates attending in person, including over 100 from industry.

Magnetic signatures of the brain characterised in UK Biobank imaging study

A study published this week in Nature Neuroscience demonstrates how studying the magnetic properties of tissue may provide a unique window into brain health and disease.